Virtual reality training to improve inhibitory control in older adults with cognitive disorders
Acceptability of a VR-based Training for Inhibitory Control in Subjects With Neurocognitive Disorders
This study tests whether using virtual reality training can help older adults with cognitive disorders improve their self-control skills.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nice Academic / other |
| Locations | 1 site (Nice) |
| Trial ID | NCT06597591 on ClinicalTrials.gov |
What this trial studies
This study evaluates the acceptability of an immersive virtual reality application designed to enhance inhibitory control in older adults diagnosed with neurocognitive disorders. Participants will engage with either a VR headset or a non-immersive tablet version of the application over four weeks, attending sessions twice a week. Throughout the intervention, they will complete questionnaires to assess the acceptability of the training. The goal is to determine how well these innovative tools can support cognitive rehabilitation in this population.
Who should consider this trial
Good fit: Ideal candidates are older adults aged 60 and above with a diagnosis of Mild Neurocognitive Disorder or slight Major Neurocognitive Disorder who exhibit deficits in inhibitory control.
Not a fit: Patients with significant vision or motor impairments, severe motion sickness, or those classified as vulnerable under French health regulations may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve cognitive function and quality of life for patients with neurocognitive disorders.
How similar studies have performed: While immersive tools for cognitive training are emerging, this specific application focusing on inhibitory control in neurocognitive disorders is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. consulting the Nice hospital Memory Center 2. diagnosis of Mild Neurocognitve Disorder or slight major neurocognitive disorder (DSM V) 3. 60 years old or more 4. presence of deficits in inhibitory control as assessed by the Frontal Assessment Battery 5. fluent in French 6. able to understand the informed consent form and voluntarily consents to participate Exclusion Criteria: 1. presence of significant vision or motor problems which would impact ability to perform the task 2. significant self-reported motion sickness 3. vulnerable persons as defined in articles L1121-5 to 8 of the French Public Health Code
Where this trial is running
Nice
- CHU de Nice — Nice, France (Recruiting)
Study contacts
- Principal investigator: Guillaume SACCO, MD — Centre Hospitalier Universitaire de Nice
- Study coordinator: Lemaire Justine
- Email: lemaire.j@chu-nice.fr
- Phone: +330492034778
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.